ERBB2 and triple-negative breast carcinoma: In addition, the pathological complete response (pCR) after NAC is a predictor of good outcome, and its prognostic value is greatest in aggressive subtypes, human epidermal growth factor receptor 2 (HER2)-enriched, and triple-negative breast cancer (TNBC) [3].